|
Volumn 369, Issue 9558, 2007, Pages 269-
|
Gliptins
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
INCRETIN;
MEMBRANE METALLOENDOPEPTIDASE;
SITAGLIPTIN;
SUBSTANCE P;
VILDAGLIPTIN;
ADAMANTANE;
ADENOSINE DEAMINASE;
DPP4 PROTEIN, HUMAN;
DRUG DERIVATIVE;
GLYCOPROTEIN;
NEUROPEPTIDE Y;
UNCLASSIFIED DRUG;
ANGIONEUROTIC EDEMA;
CHRONIC SINUSITIS;
DRUG CLASSIFICATION;
DRUG EFFECT;
DRUG MECHANISM;
DRUG MONITORING;
DRUG SAFETY;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
HUMAN;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PRIORITY JOURNAL;
RHINORRHEA;
SORE THROAT;
BLOOD;
DRUG ANTAGONISM;
NOTE;
PHYSIOLOGY;
ADAMANTANE;
ADENOSINE DEAMINASE;
ANTIGENS, CD26;
DIABETES MELLITUS, TYPE 2;
GLYCOPROTEINS;
HUMANS;
NEUROPEPTIDE Y;
|
EID: 33846384044
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(07)60135-4 Document Type: Letter |
Times cited : (10)
|
References (5)
|